FDA approves new blood test for Alzheimer’s disease
The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease, marking the fourth time such a blood test has been approved in less than two years. Roche announced Sunday that the FDA had granted approval to its Elecsys Phospho-Tau blood test for diagnosing Alzheimer’s disease.
Why It Matters
This story touches on test, fda, blood — topics readers are actively tracking. Review and add editorial context before publishing.
The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease, marking the fourth time such a blood test has been approved in less than two years. Roche announced Sunday that the FDA had granted approval to its Elecsys Phospho-Tau blood test for diagnosing Alzheimer’s disease.
It’s the fourth such…
(Original synthesis pending human/AI review — generated by the stub provider by selecting real sentences from the source material, not by writing new analysis or commentary.)
Original source: The Hill
Related Stories
Trump-backed Mazzei defeats Drummond in Oklahoma governor GOP runoff
Water crisis makes life in Sudan’s El Obeid refugee camps even worse
Trump nabs crucial primary wins in South Carolina, Oklahoma: 4 takeaways
